Μετάβαση στο περιεχόμενο

Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds

Biosimilarity and pharmacokinetic descriptors were obtained using SwissADME and ADMETlab 2.0 web services. Analysis of the obtained descriptors shows that, according to Lipinski's rule, quinoxalyl hydrazones of 2-hydroximino-1,3-dioxocompounds may be promising candidates for drug development fo...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Anenko, D. S., Аненко, Д. С., Glizhova, T. N., Глижова, Т. Н.
Μορφή: Статья
Γλώσσα:English
Έκδοση: 2024
Θέματα:
Διαθέσιμο Online:https://dspace.ncfu.ru/handle/20.500.12258/26895
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
id ir-20.500.12258-26895
record_format dspace
spelling ir-20.500.12258-268952024-03-07T08:48:27Z Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds Anenko, D. S. Аненко, Д. С. Glizhova, T. N. Глижова, Т. Н. Antioxidant activity Quinoxalyl hydrazones of 2-hydroxyimino-1,3-dicarbonyl compounds Biosimilarity and pharmacokinetic descriptors were obtained using SwissADME and ADMETlab 2.0 web services. Analysis of the obtained descriptors shows that, according to Lipinski's rule, quinoxalyl hydrazones of 2-hydroximino-1,3-dioxocompounds may be promising candidates for drug development for oral administration. Analysis of the pharmacokinetic descriptors of the structures studied shows that, according to the in silico predictions, the compounds can penetrate the blood-brain barrier, be absorbed in the gastrointestinal tract, bind to plasma proteins, be rapidly eliminated from target cells and inhibit CYP3A4, CYP1A2, CYP2C19 and CYP2D6 isoenzymes. The antioxidant activity of quinoxalyl hydrazone derivatives with different benzoyl, ester and acetyl moieties has been studied. Pharmacological screening of the obtained compounds was performed in vitro in the model of Fe2+-induced lipid peroxidation. The data of pharmacological screening indicate clearly pronounced inhibition of lipid peroxidation in the system of yolk lipoproteins by the compounds obtained, which indicates a significant contribution of quinoxalone scaffold in the manifestation of antioxidant properties. Variations in the structure of the starting 1,3-dicarbonyl compounds did not result in significant changes in the antioxidant activity of the obtained hydrazones. The compounds obtained can be promising compounds with marked antioxidant activity for further in vivo studies, including investigation of acute and chronic toxicity. The leading compound is tolyl-substituted quinoxalyl hydrazone IIb. 2024-03-07T08:46:41Z 2024-03-07T08:46:41Z 2023 Статья Anenko, DS; Bobrov, PS; Abisalova, IL; Suboch, GA; Sergeeva, EO; Glizhova, TN. Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds // CHEMISTRY FOR SUSTAINABLE DEVELOPMENT. - 2023. - 31(4). - рр. 349-353. - DOI: 10.15372/CSD2023477 http://hdl.handle.net/20.500.12258/26895 en CHEMISTRY FOR SUSTAINABLE DEVELOPMENT application/pdf
institution СКФУ
collection Репозиторий
language English
topic Antioxidant activity
Quinoxalyl hydrazones of 2-hydroxyimino-1,3-dicarbonyl compounds
spellingShingle Antioxidant activity
Quinoxalyl hydrazones of 2-hydroxyimino-1,3-dicarbonyl compounds
Anenko, D. S.
Аненко, Д. С.
Glizhova, T. N.
Глижова, Т. Н.
Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
description Biosimilarity and pharmacokinetic descriptors were obtained using SwissADME and ADMETlab 2.0 web services. Analysis of the obtained descriptors shows that, according to Lipinski's rule, quinoxalyl hydrazones of 2-hydroximino-1,3-dioxocompounds may be promising candidates for drug development for oral administration. Analysis of the pharmacokinetic descriptors of the structures studied shows that, according to the in silico predictions, the compounds can penetrate the blood-brain barrier, be absorbed in the gastrointestinal tract, bind to plasma proteins, be rapidly eliminated from target cells and inhibit CYP3A4, CYP1A2, CYP2C19 and CYP2D6 isoenzymes. The antioxidant activity of quinoxalyl hydrazone derivatives with different benzoyl, ester and acetyl moieties has been studied. Pharmacological screening of the obtained compounds was performed in vitro in the model of Fe2+-induced lipid peroxidation. The data of pharmacological screening indicate clearly pronounced inhibition of lipid peroxidation in the system of yolk lipoproteins by the compounds obtained, which indicates a significant contribution of quinoxalone scaffold in the manifestation of antioxidant properties. Variations in the structure of the starting 1,3-dicarbonyl compounds did not result in significant changes in the antioxidant activity of the obtained hydrazones. The compounds obtained can be promising compounds with marked antioxidant activity for further in vivo studies, including investigation of acute and chronic toxicity. The leading compound is tolyl-substituted quinoxalyl hydrazone IIb.
format Статья
author Anenko, D. S.
Аненко, Д. С.
Glizhova, T. N.
Глижова, Т. Н.
author_facet Anenko, D. S.
Аненко, Д. С.
Glizhova, T. N.
Глижова, Т. Н.
author_sort Anenko, D. S.
title Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
title_short Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
title_full Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
title_fullStr Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
title_full_unstemmed Antioxidant Activity of Quinoxalyl Hydrazones of 2-Hydroxyimino-1,3-dicarbonyl Compounds
title_sort antioxidant activity of quinoxalyl hydrazones of 2-hydroxyimino-1,3-dicarbonyl compounds
publishDate 2024
url https://dspace.ncfu.ru/handle/20.500.12258/26895
work_keys_str_mv AT anenkods antioxidantactivityofquinoxalylhydrazonesof2hydroxyimino13dicarbonylcompounds
AT anenkods antioxidantactivityofquinoxalylhydrazonesof2hydroxyimino13dicarbonylcompounds
AT glizhovatn antioxidantactivityofquinoxalylhydrazonesof2hydroxyimino13dicarbonylcompounds
AT gližovatn antioxidantactivityofquinoxalylhydrazonesof2hydroxyimino13dicarbonylcompounds
_version_ 1809808873229385728